Trial intelligence / Profile preview

Vancomycin Administration Routes in Total Knee Arthroplasty

NCT07282782Phase 4Recruiting

Sponsor
University of California, San Diego
Start
Jun 2024
Primary completion
Dec 2026
Modality
Cyclic Peptides, Antimicrobial Peptides, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of vancomycin in periprosthetic joint infection (PJI), sponsored by University of California, San Diego. Started Jun 2024; status: recruiting.

02

Drugs

vancomycin
03

Conditions

periprosthetic joint infection (PJI)

Beyond the preview

Go deeper on NCT07282782.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07282782.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call